EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

World Media Directory · RSS · Email Newsletters

There were 1,619 press releases posted in the last 24 hours and 430,805 in the last 365 days.

Press Releases on November 12, 2024

2,033 Press Releases

Published on November 12, 2024 - 21:01 GMT

89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic …

Distribution channels: Technology ...
Published on November 12, 2024 - 21:01 GMT

Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

U.S. FDA approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of 2025 Total revenues for the third quarter ended September 30, …

Distribution channels:
Published on November 12, 2024 - 21:01 GMT

Fate Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; Second Treatment Arm Adding FT819 to Maintenance Therapy without Conditioning Chemotherapy Opened for Enrollment FT522 Multi-indication …

Distribution channels:
Published on November 12, 2024 - 21:01 GMT

Voyager Reports Third Quarter 2024 Financial and Operating Results

- Enrollment and dosing complete in single ascending dose clinical trial of anti-tau antibody VY7523 for Alzheimer’s; on track to generate top-line data H1 2025 - - Recent third-party clinical data establish that an antibody can inhibit tau accumulation in …

Distribution channels: Business & Economy, Technology ...
Published on November 12, 2024 - 21:01 GMT

Erasca Reports Third Quarter 2024 Business Updates and Financial Results

Positive preliminary Phase 1b data in SEACRAFT-1 NRASm melanoma cohort bolsters conviction in ongoing SEACRAFT-2 registrational trial; Stage 1 randomized data expected in 2025 Strong execution across potentially best-in-class RAS targeting franchise; …

Distribution channels:
Published on November 12, 2024 - 21:01 GMT

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Jefferies London Healthcare Conference on Tuesday, November 19, 2024 at 12: …

Distribution channels:
Published on November 12, 2024 - 21:01 GMT

Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, plans to …

Distribution channels:
Published on November 12, 2024 - 21:01 GMT

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing Cohort Interim Data from Atopic Dermatitis Trial Expected to be Announced December 2024 Registration Phase 3 Clinical Trial of Soquelitinib in Peripheral T Cell …

Distribution channels:
Published on November 12, 2024 - 21:01 GMT

Xenon Reports Q3 2024 Financial Results and Business Update

– Phase 3 epilepsy program advancing with X-TOLE2 topline FOS data anticipated in H2 2025 – Long-term azetukalner results from X-TOLE open-label extension study in FOS to be presented at AES – Phase 3 MDD program on track with X-NOVA2 study expected to …

Distribution channels:
Published on November 12, 2024 - 21:01 GMT

Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Presented compelling new preclinical data demonstrating anti-tumor activity for OP-3136, a novel KAT6 inhibitor, with enhanced activity of palazestrant combinations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024) New …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on November 12, 2024 - 21:01 GMT

Alliance Entertainment Reports First Quarter Fiscal Year 2025 Results

Operational efficiencies drove improved profitability Strengthened balance sheet including 33% reduction in revolver debt Higher-margin Direct to Consumer sales increased to 34% of gross revenue PLANTATION, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alliance …

Distribution channels: Business & Economy, Retail ...
Published on November 12, 2024 - 21:01 GMT

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

CANTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on November 12, 2024 - 21:01 GMT

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Completed enrollment of Phase 2 BESTOW trial of tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Announced positive initial data from first three subjects with type 1 diabetes …

Distribution channels:
Published on November 12, 2024 - 21:01 GMT

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted share Entered into an asset purchase agreement to acquire Increlex® (mecasermin injection) Q3 2024 product sales increased 40% over Q3 2023, representing 15th …

Distribution channels:
Published on November 12, 2024 - 21:01 GMT

ElectroCore’s Truvaga™ Plus Wins Men’s Health Magazine Tech Award

ROCKAWAY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness product, Truvaga Plus, has been awarded the prestigious Men’ …

Distribution channels:
Published on November 12, 2024 - 21:00 GMT

Jason Owen Launches Into The Christmas Spirit With ‘All I Want For Christmas Is You’

Jason Owen returns with his country rock version of the classic ‘All I Want For Christmas Is You’ just in time for the festive season. NEW SOUTH WALES, AUSTRALIA, November 13, 2024 /⁨EINPresswire.com⁩/ -- Can you believe that it has been thirty years …

Distribution channels: Movie Industry, Music Industry ...
Published on November 12, 2024 - 21:00 GMT

BMBL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bumble Inc. Investors with Substantial Losses Have ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Bumble Inc. (“Bumble” or “the Company”) ( …

Distribution channels: Consumer Goods, Law ...
Published on November 12, 2024 - 21:00 GMT

JBI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Janus International Group, Inc. and ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Janus International Group, Inc. (“Janus” or “the Company”) (NYSE: JBI). Investors who …

Distribution channels: Consumer Goods, Law ...
Published on November 12, 2024 - 21:00 GMT

SUNLQ INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sunlight Financial Holdings, Inc. f/k/a Spartan Acquisition ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sunlight Financial Holdings, Inc. f/k/a …

Distribution channels: Consumer Goods, Law ...
Published on November 12, 2024 - 21:00 GMT

FNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Paragon 28, Inc. Investors with Substantial Losses Have ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Paragon 28, Inc. (“Paragon 28” or “the …

Distribution channels: Consumer Goods, Law ...

Previous 14 15 16 17 18 19 20 21 22 23 24 Next

Previous Day 2024 Calendar Next Day